Page last updated: 2024-10-29

avapro and Complication, Postoperative

avapro has been researched along with Complication, Postoperative in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Haddad, MA1
Zalawadiya, SK1
Awdallah, H1
Sabet, S1
El-Haddad, HA1
Mostafa, A1
Rashed, A1
El-Naggar, W1
Farag, N1
Saleb, MA1
Jacob, S1
Coleman, CI1
Makanji, S1
Kluger, J1
White, CM1

Trials

1 trial available for avapro and Complication, Postoperative

ArticleYear
Role of irbesartan in prevention of post-coronary artery bypass graft atrial fibrillation.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2011, Aug-01, Volume: 11, Issue:4

    Topics: Age Factors; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Biphenyl Compounds; Coron

2011

Other Studies

1 other study available for avapro and Complication, Postoperative

ArticleYear
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:3

    Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhi

2007